| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |